Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.78) by 2.56 percent. This is unchanged from the same period last year.
DiDi Shares Drop After Q2, Q3 Results
DiDi Global Inc (NYSE: DIDI)